Skip to main content

Sirna Therapeutics, UC Davis, CombiMatrix


Sirna Seeks Director of Alliance Management

Sirna Therapeutics has begun looking for a director of alliance management, a position that will be based out of its San Francisco headquarters, according to the company's website.

The director "will be instrumental in maintaining successful alliances between Sirna and its industry, government, academic partners, and collaborators, as well as function as the senior customer advocate within Sirna," the company said. "The position will establish account management strategies, design and implement account management functions and will manage the operational, technical and financial aspects of Sirna's alliances."

Sirna President and CEO Howard Robin noted at the recent JPMorgan Healthcare Conference in San Francisco that the company anticipates signing one major partnership with a big pharma during 2006 (see RNAi News, 1/19/2006).

The director of alliance management will report to Sirna's senior vice president of corporate development, Michael French.

UC Davis Joins CombiMatrix's Core Access Program

The University of California, Davis, has joined CombiMatrix's CombiCore access program, Combi parent Acacia Research said this week.

Under the non-exclusive agreement, all UC Davis researchers can purchase, through the UC Davis Genome Center, CombiMatrix's CustomArrays and CatalogArrays, including array processing services performed at the UC Davis Genome Center.

Financial details were not disclosed.

This is the second university CombiMatrix has signed on to its CombiCore program, which the company initiated this quarter. Earlier this month it signed an agreement with the University of Colorado.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.